Vanda Pharmaceuticals (VNDA) Q3 2024 Earnings

31JulConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.19
-0.11
-0.03
0.05

Details

Expected EPS
-0.19
Actual EPS
-0.08
Surprise EPS
0.11
Surprise Percent
+57.89%

Description

Vanda Pharmaceuticals (VNDA) has reported earnings of -0.08 per share for Q3 2024.

0 Comments

Share your thoughts